OpenArc Corporate Advisory’s JPMorgan Chase JPM Stock Holding History

OpenArc Corporate Advisory’s Portfolio JPM Stock Details JPM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.2M	Buy	83,239 +2,559	+3%	+$795K	0.32%	53
2026 Q1	$23.7M	Buy	80,680 +6,524	+9%	+$1.98M	0.34%	50
2025 Q4	$23.9M	Buy	+74,156	New	+$23M	0.4%	42

Other funds holding JPM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

OpenArc Corporate Advisory's JPM Position: Q2 2026 in Review

OpenArc Corporate Advisory increased its JPMorgan Chase (JPM) stake by 3.2% in Q2 2026, buying an estimated $795K and bringing the position to 83,239 shares worth $27.2M. The position accounts for 0.32% of the portfolio, ranked #53.

OpenArc Corporate Advisory first reported a position in JPM in Q4 2025 and has held it in 3 quarters since. 5,117 funds tracked by Wall St. Rank hold JPM as of Q2 2026.

OpenArc Corporate Advisory held 83,239 shares of JPMorgan Chase worth $27.2M as of Q2 2026.
OpenArc Corporate Advisory bought 2,559 JPMorgan Chase shares in Q2 2026, an estimated $795K.
JPMorgan Chase made up 0.32% of OpenArc Corporate Advisory's portfolio in Q2 2026, its #53 holding.
OpenArc Corporate Advisory first reported a position in JPMorgan Chase in Q4 2025 and has held it in 3 quarters since.
5,117 funds tracked by Wall St. Rank held JPMorgan Chase as of Q2 2026.

Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.